Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2020-05-28FDA Approved: DIFICID — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for DIFICID (fidaxomicin) from Merck, updating the product labeling.